Trial Profile
Prospective observational study of Mylotarg (gemtuzumab ozogamicin) in usual care
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jul 2007
Price :
$35
*
At a glance
- Drugs Gemtuzumab ozogamicin (Primary)
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia
- Focus Adverse reactions
- 22 Oct 2005 New trial record.